Jed Latkin, Chief Executive Officer of Windtree comments on the Company's interim results of the SEISMiC C study to be presented at the @HFSA Annual Scientific Meeting 2025. Learn more: #HSFA2025

Windtree announced that istaroxime was chosen for a presentation entitled, “Safety and Efficacy of intravenous administration of istaroxime for 48 hours in patients with SCAI Stage C cardiogenic shock due to heart failure” at the #HSFA2025. $WINT

“The results of the SEISMIC C interim analysis are exciting,” said Jed Latkin, CEO of Windtree. “We believe these data will be instrumental in moving istaroxime to a global Phase 3 program in heart failure and cardiogenic shock." Learn more: $WINT

The effects on hemodynamic and echocardiographic measures appeared to be consistent with results seen in previous istaroxime studies. $WINT.

The Phase 2 interim analysis included the first 20 patients enrolled in the study. There were no new safety concerns identified, and no apparent excess arrhythmias in patients treated with istaroxime when given with standard of care therapies. $WINT

Steve Simonson, Chief Medical Officer of Windtree, comments on the Company's istaroxime Phase 2 interim analysis in SCAI stage C cardiogenic shock patients. Discover more: $WINT

A Phase 2 study showed istaroxime had a similar profile to that seen in previous studies despite a greater severity of illness and being used in addition to currently available inotropes and vasopressors. Find details: $WINT

Windtree has performed a planned interim analysis of the SEISMiC C Phase 2 study data evaluating istaroxime in SCAI Stage C cardiogenic shock. Find details: $WINT

Windtree CEO Jed Latkin comments on the Company's large reduction of preferred series C and D shares outstanding by conversion and redemption. Learn more: $WINT

Windtree announced large reductions in outstanding shares of its preferred series C and D shares. 99% of outstanding preferred series C shares are redeemed or converted and preferred series D have been reduced 68.5% in outstanding shares. Find details:

Windtree CEO Jed Latkin comments on the Company's common stock purchase agreement to establish an equity line of credit and bolster its BNB cryptocurrency treasury strategy. Learn more: $WINT

Establishing the ELOC reflects Windtree’s strategy to diversify its assets & leverage the potential of blockchain-based digital currencies. We remain committed to prudent financial management while exploring innovative avenues to drive value. $WINT

The company also entered into an additional $20 million stock purchase agreement with Build and Build Corp. Ninety-nine percent of the proceeds from the ELOC and Build and Build Corp will be allocated to acquiring BNB cryptocurrency. $WINT

Windtree has entered into a Common Stock Purchase Agreement for up to $500 million to establish an equity line of credit and bolster its BNB cryptocurrency treasury strategy. Learn more: $WINT

This partnership positions Windtree to leverage Kraken's industry-leading security, liquidity, and expertise in digital asset management to support its pioneering BNB-focused treasury strategy, encompassing custody, security, and yield generation. $WINT

Windtree, the first NASDAQ-listed company offering pure play direct exposure to the BNB token, the fifth-largest blockchain by market capitalization (over $100B), expects the collaboration with Kraken to enhance its ability to provide secure access. $WINT

"We are excited to partner with Kraken, a trusted leader in the cryptocurrency industry, to support our groundbreaking BNB strategy," said Jed Latkin, Chief Executive Officer of Windtree. "Kraken's expertise and secure platform will strengthen our ability."

Windtree announced a strategic partnership with Kraken, a leading global cryptocurrency platform, to provide custody, trading, and over-the-counter (OTC) services for Windtree's BNB Crypto Treasury Strategy. $WINT

Jed Latkin, CEO of Windtree, comments on the Company's potential BNB crypto treasury strategy launch with Build and Build Corp. Discover more: $WINT

Subject to shareholder approval & the satisfaction of other closing conditions, $WINT will become the first NASDAQ-listed company offering direct exposure to the BNB token, the fifth-largest blockchain by market capitalization (over $95 billion).